Huntington Bancshares heads into late April with a curious split: the Street remains firmly in the bull camp, yet short sellers have been adding positions all week — a quiet but persistent divergence worth watching.
The analyst consensus is as uniformly positive as it gets for a regional bank. JP Morgan and Morgan Stanley both hold Overweight ratings, Evercore and Truist carry Outperform and Buy respectively — all maintained through the recent round of cuts. What changed is the price target, not the conviction. Every major firm that touched the stock in the past few weeks trimmed its target, mostly from the $21 range down to $19, leaving the mean target around $19.70. With the stock at $16.31, implied upside is roughly 21%. The bear case centres on integration risk from acquisitions and rate sensitivity; the bulls point to the bank's position as the 15th largest US commercial bank, projected EPS growth, and a forward earnings yield running close to 10.5%.
Short positioning is moving in the wrong direction — but not alarmingly so. Short interest climbed roughly 7.8% over the past week to 4.5% of the free float, partially recovering from a 5.7% decline over the prior month. The sharpest jump came mid-week, around April 23-24, when estimated short shares rose from roughly 66 million to 70 million. That's worth noting after the Q1 earnings release on April 23 produced a 1-day decline of about 2.5%. The borrow market, however, tells a relaxed story. Cost to borrow dropped to 0.30% on April 28 — the lowest level of the past six weeks and down about 10% on the week. Availability remains very loose, with lending pool demand far from any stress level. Shorts are adding, but they're not paying up to do it.
Options positioning has tilted modestly more defensive. The put/call ratio edged to 0.64 this week, about 1.5 standard deviations above its 20-day average of 0.60. That's not an extreme read — the 52-week high is 0.74 — but the direction has been clear since early April, when PCR was running in the high 0.58 range. Options traders are buying slightly more downside protection than usual, consistent with the post-earnings drift lower and some uncertainty about the macro environment for regional banks.
The institutional picture is broadly stable and well-held. Vanguard and BlackRock together own more than 17% of shares. Wellington Management stands out with a reported addition of over 68 million shares as of late February — making it the fourth-largest holder at 3.5% of shares outstanding. That's a meaningful position build for an active manager of Wellington's profile, though it predates the current week by two months. On the insider side, CEO Stephen Steinour bought roughly $500,000 worth of stock on March 12 at $15.49 — a signal worth logging, even though it followed a larger open-market sale by the same executive on March 9. The net insider position over 90 days is positive, with net share purchases of around 715,000 shares, but the mixed signal from the CEO's sell-then-buy pattern reduces its interpretive weight.
Peers have tracked HBAN closely this week. FITB fell 1.5% and PNC dropped 2.8% — both worse than HBAN's 3% weekly decline — while ZION managed a small gain of 1%. The sector-wide pressure suggests macro headwinds rather than HBAN-specific concerns. Valuation multiples reflect the month's partial recovery: price-to-book is at 1.04x, up roughly 3% over 30 days, while the PE multiple has edged to 9.55x. Forward EPS year-on-year growth ranks in the 99th percentile by factor score — a standout figure — though near-term momentum scores (30-day and 90-day EPS momentum in the 33-37th percentile range) suggest the market is not yet fully pricing in that longer-term optimism.
The next scheduled earnings event is July 23. Between now and then, the key tension is whether shorts — who added positions immediately after the Q1 print — continue building, or whether the Street's unanimous positive ratings and widening discount to target price attract buyers who absorb that pressure first.
See the live data behind this article on ORTEX.
Open HBAN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
